CellCentric vs Orthogon Therapeutics
CellCentric vs Orthogon Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Orthogon Therapeutics on 49/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 49/100
- domain rating: 35/100 against 6/100
- headcount: 53 against 3
- funding raised: $375M against $34.6M
- LinkedIn following: 28,695 against 1,121
Orthogon Therapeutics
- agent readiness: 50/100 against 32/100
At a glance
| Measure | CellCentric | Orthogon Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Developing first-in-class oral therapy for BK polyomavirus infections. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2003 | 2012 |
| Headquarters | Cambridge, United Kingdom | Canton, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CellCentric | Orthogon Therapeutics |
|---|---|---|
| Employees | 53 | 3 |
| Total funding | $375M | $34.6M |
| Latest round | Series D | Follow-on |
| LinkedIn followers | 28,695 | 1,121 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Orthogon Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 49/100 |
| Traction | 57/100 | 44/100 |
| Team | 60/100 | 30/100 |
| Search visibility | 44/100 | 33/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Orthogon Therapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CellCentric vs Orthogon Therapeutics: common questions
Which is better, CellCentric or Orthogon Therapeutics?
On our 0-100 score CellCentric rates higher (60/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do CellCentric and Orthogon Therapeutics compare on the numbers?
CellCentric leads on our overall score (60/100 against 49/100), domain rating (35/100 against 6/100), headcount (53 against 3), funding raised ($375M against $34.6M), LinkedIn following (28,695 against 1,121). Orthogon Therapeutics leads on agent readiness (50/100 against 32/100).
Read the full CellCentric review and pricing or the Orthogon Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.